Price Alert

Pediatrix Medical Group I... (MD)

NYSE: MD · Real-Time Price · USD

15.83

0.29 (1.87%)

At close: Aug 15, 2025, 12:25 PM

Pediatrix Medical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	468.84M	458.36M	502.36M	511.16M	504.3M	495.1M	496.44M	506.61M	500.58M	491.01M	513.84M	489.92M	486.03M	482.23M	498.53M	492.95M	472.96M	446.75M
Cost of Revenue	344.12M	355.72M	373.84M	394.34M	398.97M	410.53M	395.28M	399.72M	385.12M	392.95M	398.04M	374.71M	360.6M	371.64M	360.63M	354.88M	341.22M	341.22M
Gross Profit	124.73M	102.64M	121.65M	116.82M	105.33M	84.57M	101.17M	106.89M	115.46M	98.05M	115.81M	115.21M	125.43M	110.58M	137.9M	138.07M	131.74M	105.53M
Operating Income	59.87M	32.1M	39.29M	33.83M	48.76M	24.37M	-111.49M	40.27M	48.5M	30.04M	56.02M	47.39M	50.16M	39.11M	68M	58.79M	50.02M	26.1M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	54.97M	28.09M	33.33M	25.23M	-167.73M	7.82M	-138.85M	30.83M	38.95M	20.71M	27.82M	38.86M	43.03M	-28.35M	53.52M	43.43M	37.89M	389K
Net Income	39.26M	20.74M	30.48M	19.44M	-153.03M	4.04M	-124.29M	40.27M	28.28M	14.21M	29.66M	30.73M	27.14M	-20.95M	47.52M	30.8M	35.01M	17.64M
Selling & General & Admin	55.71M	58.6M	63.55M	58.12M	56.56M	60.2M	53.06M	57.41M	58.01M	59.06M	51.06M	57.89M	61.16M	61.29M	58.98M	66.89M	70.97M	66.52M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	9.15M	11.94M	n/a	24.87M	n/a	n/a	159.59M	9.21M	8.95M	8.95M	9.14M	8.96M	8.78M	8.77M	7.86M	8.15M	8.11M	8.03M
Operating Expenses	64.86M	70.54M	63.55M	82.99M	56.56M	60.2M	62.13M	66.62M	66.96M	68.01M	60.19M	66.84M	69.94M	70.06M	66.84M	75.04M	79.07M	74.55M
Interest Expense	9.13M	9.15M	9.71M	10.13M	10.31M	10.6M	10.08M	10.37M	11.23M	10.39M	9.95M	9.52M	8.41M	11.82M	16.6M	17.59M	16.88M	17.64M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	408.98M	426.26M	463.07M	477.33M	455.53M	470.73M	457.4M	466.34M	452.08M	460.97M	458.23M	441.55M	430.54M	441.7M	427.47M	429.92M	420.29M	415.77M
Income Tax Expense	15.71M	7.35M	2.85M	5.79M	-14.7M	3.79M	-14.56M	-9.44M	10.66M	6.51M	3.82M	10.05M	12.33M	-7.4M	13.24M	11.59M	7.36M	-4.96M
Shares Outstanding (Basic)	86.85M	85.81M	85.87M	83.89M	83.33M	84.01M	84.02M	82.54M	82.4M	81.89M	82.95M	82.13M	85.08M	84.74M	85.07M	85.06M	84.91M	84.53M
Shares Outstanding (Diluted)	86.85M	85.81M	85.87M	84.52M	83.33M	83.28M	82.66M	82.95M	82.66M	82.32M	82.95M	82.78M	85.62M	85.41M	86.42M	86.1M	85.93M	85.49M
EPS (Basic)	0.45	0.24	0.35	0.23	-1.84	0.05	-1.48	0.49	0.34	0.17	0.36	0.37	0.32	-0.25	0.55	0.36	0.41	0.21
EPS (Diluted)	0.45	0.24	0.35	0.23	-1.84	0.05	-1.5	0.49	0.34	0.17	0.36	0.37	0.32	-0.25	0.55	0.36	0.41	0.21
EBITDA	69.41M	42.58M	49.91M	41.62M	-148.63M	34.68M	-119.71M	49.48M	57.44M	38.99M	64.75M	57.32M	64.27M	-7.76M	78.92M	71.18M	60.77M	39.01M
EBIT	64.1M	37.24M	43.04M	35.36M	-157.42M	24.37M	-128.77M	40.27M	48.5M	30.04M	55.61M	48.36M	55.49M	-16.53M	71.06M	63.02M	52.67M	30.98M
Depreciation & Amortization	5.31M	5.33M	6.87M	6.25M	8.79M	10.31M	9.06M	9.21M	8.95M	8.95M	9.14M	8.96M	8.78M	8.77M	7.86M	8.15M	8.11M	8.03M